New Enterprise Associates
http://www.nea.com/Home/New Enterprise Associates is a venture capital firm based in Baltimore, MD. The firm has backed more than 160 companies that have gone public and invested in more than 230 companies that have been successfully merged or acquired. NEA focuses its investments in the information technology, healthcare, and energy technology industries. While NEA makes a majority of its investments in the United States, the firm invests around the world in China and India. The firm was founded in 1978.
View Older Stories View More Recent Stories
-
Gilead Sciences (GILD) will acquire 49.9% equity interest in Pionyr Immunotherapeutic for $275 million
-
Gilead Sciences Secures Exclusive Option to Acquire Pionyr Immunotherapeutics
-
Form 4 AVEO PHARMACEUTICALS, For: Jun 19 Filed by: New Enterprise Associates 15, L.P.
-
Form SC 13D/A ARDELYX, INC. Filed by: New Enterprise Associates 12, Limited Partnership
-
DataRobot Rolls Out Enhancements to Enterprise AI Platform Designed to Drive Greater Business Value from AI
-
CINDE Announces: Coursera and Costa Rica Launch a Joint Program to Strengthen Industry 4.0 Skills and Train - Free of Charge - 50,000 People to Confront the COVID-19 Crisis
-
DataRobot Announces 10x: The Applied Data Science Academy to Expand Education and Access to Jobs in Rapidly Growing Data Science Field
-
Topia Launches Next Generation Global Talent Mobility Platform, Giving Enterprises an Edge in a Competitive, Unpredictable Talent Market
-
Novavax (NVAX) Announces David Mott to Board
-
Novavax Appoints Biotechnology Veteran David Mott to Board of Directors
-
Novavax Appoints Biotechnology Veteran David Mott to Board of Directors
-
Form SC 13D/A Senseonics Holdings, Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
CIT GAP Funds Invests in Agrology to Increase the Precision of Agriculture
-
Form 4 ARDELYX, INC. For: Jun 10 Filed by: New Enterprise Associates 12, Limited Partnership
-
DataRobot to Host Inaugural AI Experience Worldwide Conference, “Accelerating the Impact of AI in Changing Times”
-
Skyhook Chooses OmniSci to Support Mobility Indexing In Next Phase of COVID-19 Response
-
DataRobot Acquires Boston Consulting Group’s SOURCE AI Technology, Kicking Off Industry-First Strategic Partnership
-
Affinia Therapeutics Announces Appointment of Elliott Sigal, M.D., Ph.D. to the Company’s Board of Directors
-
Affinia Therapeutics Announces Appointment of Elliott Sigal, M.D., Ph.D. to the Company’s Board of Directors
-
CIT Investment Director Marco Rubin Co-Hosts New Podcast Series for Entrepreneurs
-
Complexa Completes Patient Enrollment in Phase 2 FIRSTx Trial Evaluating CXA-10 in Focal Segmental Glomerulosclerosis, a Rare and Severe Form of Kidney Disease
-
CIT GAP Funds Invests in Scout Inc. to Fundamentally Change the Spaceflight Risk Environment
-
OrphoMed Resumes Recruitment for Phase 2 Adaptive Design Study of ORP-101 for Treatment of IBS-D
-
Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
-
Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
-
CIT GAP Funds Makes Follow-On Investment in MetiStream
-
Form SC 13D/A Senseonics Holdings, Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
Lumos Pharma to Participate in the Jefferies 2020 Healthcare Conference
-
Lumos Pharma to Participate in the Jefferies 2020 Healthcare Conference
-
OmniSci Welcomes SafeGraph and Veraset to Its Data Catalog, Providing POI/GPS Data for Commercial, Business, Government
-
“Father of SSL” and Public-Key Cryptography Co-Inventor Headline Beyond Identity’s Technical Advisory Board
-
“Father of SSL” and Public-Key Cryptography Co-Inventor Headline Beyond Identity’s Technical Advisory Board
-
Lumos Pharma to Report First Quarter 2020 Financial Results and Host a Conference Call on May 28, 2020
-
Lumos Pharma to Report First Quarter 2020 Financial Results and Host a Conference Call on May 28, 2020
-
Monte Rosa Therapeutics Discloses $32.5 Million Financing
-
Form 4 Cloudflare, Inc. For: May 19 Filed by: NEW ENTERPRISE ASSOCIATES 13 LP
-
Form SC 13D/A Senseonics Holdings, Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
Aetion Launches Research Collaboration with FDA to Advance Understanding of COVID-19
-
Amplyx Pharmaceuticals Adds Pfizer and Adage to Series C Financing, Bringing Total to over 90 Million
-
ChromaCode Raises $10 Million Series C Financing From Adjuvant Capital
-
Ergomed Enters Strategic Collaboration to Drive Pharmacovigilance Leadership in Intelligent Automation
-
Ergomed Enters Strategic Collaboration to Drive Pharmacovigilance Leadership in Intelligent Automation
-
OmniSci Records Best Quarter in Company History
-
CIT GAP Funds Makes Follow-On Investment in Fenris
-
ForAllSecure Awarded $45 Million Contract to Deploy Mayhem Across Branches of U.S. Department of Defense
-
CIT GAP Funds Invests in RoundlyX to Support a New Generation of Cryptocurrency Investors
-
SetPoint Medical Receives IDE Approval for U.S. Pivotal Trial to Study its Bioelectronic Platform in Rheumatoid Arthritis Patients
-
Form 4 Bloom Energy Corp For: Mar 31 Filed by: NEW ENTERPRISE ASSOCIATES 10 L P
-
Mojo Vision Raises Additional $51 Million+ in Series B-1 Round, Funding Development of First True Smart Contact Lens
-
Topia Raises $15 Million in Series D Funding

